RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. At Amaryllis Nucleics, our technology breaks down these barriers by cutting time and cost manyfold — empowering researchers and accelerating important discoveries in genomics. Amaryllis Nucleics is a University of California-Davis spinoff. While at UC-Davis, we synthesized, sequenced, and analyzed several thousand RNA-seq libraries. To address the major time and cost bottlenecks we spent two years developing and optimizing a novel approach to RNA-seq library synthesis. Together, we have 36 years of molecular biology and bioinformatics experience. As proponents of open science and open-source software, our motivation is to democratize RNA sequencing and make it more accessible to researchers worldwide. We want to empower scientists to make important innovations.
Amaryllis Nucleics has not received any reviews.
Amaryllis Nucleics has not received any endorsements.